Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?

Journal of Hepatology

Volumn 53, Issue 5, 2010, Pages 976-980

  Thabut, Dominique ^a,b   Shah, Vijay ^a  

^a MAYO CLINIC   (United States)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Angiogenesis; Cirrhosis; Portal hypertension; Receptor tyrosine kinase; Vascular remodeling

Indexed keywords

SORAFENIB; SUNITINIB;

ANGIOGENESIS; CHRONIC LIVER DISEASE; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER SINUSOID; NONHUMAN; PARACRINE SIGNALING; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; VASCULAR RESISTANCE;

EID: 77957328518     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.07.004     Document Type: Note

References (47)

1. Y. Iwakiri, M. Grisham, and V. Shah Vascular biology and pathobiology of the liver: Report of a single-topic symposium Hepatology 47 5 2008 1754 1763
2. D.C. Rockey, and V. Shah Nitric oxide biology and the liver: report of an AASLD research workshop Hepatology 39 1 2004 250 257
3. N. Kawada, H. Klein, and K. Decker Eicosanoid-mediated contractility of hepatic stellate cells Biochem J 285 Pt 2 1992 367 371
4. M. Pinzani, P. Failli, C. Ruocco, A. Casini, S. Milani, and E. Baldi Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients J Clin Invest 90 2 1992 642 646
5. V. Shah, M. Toruner, F. Haddad, G. Cadelina, A. Papapetropoulos, and K. Choo Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat Gastroenterology 117 5 1999 1222 1228
6. C. Housset, D.C. Rockey, and D.M. Bissell Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1 Proc Natl Acad Sci USA 90 20 1993 9266 9270
7. M. Suematsu, N. Goda, T. Sano, S. Kashiwagi, T. Egawa, and Y. Shinoda Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver J Clin Invest 96 5 1995 2431 2437
8. M. Fernandez, D. Semela, J. Bruix, I. Colle, M. Pinzani, and J. Bosch Angiogenesis in liver disease J Hepatol 50 3 2009 604 620
9. A.M. Rappaport, P.J. MacPhee, M.M. Fisher, and M.J. Phillips The scarring of the liver acini (Cirrhosis). Tridimensional and microcirculatory considerations Virchows Arch A Pathol Anat Histopathol 402 2 1983 107 137
10. J.S. Lee, D. Semela, J. Iredale, and V.H. Shah Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 45 3 2007 817 825
11. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 7070 2005 932 936
12. C. Corpechot, V. Barbu, D. Wendum, N. Kinnman, C. Rey, and R. Poupon Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis Hepatology 35 5 2002 1010 1021
13. S. Lee, T.T. Chen, C.L. Barber, M.C. Jordan, J. Murdock, and S. Desai Autocrine VEGF signaling is required for vascular homeostasis Cell 130 4 2007 691 703
14. D. Semela, A. Das, D. Langer, N. Kang, E. Leof, and V. Shah Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function Gastroenterology 135 2 2008 671 679
15. K. Taura, S. De Minicis, E. Seki, E. Hatano, K. Iwaisako, and C.H. Osterreicher Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis Gastroenterology 135 5 2008 1729 1738
16. S. Aleffi, I. Petrai, C. Bertolani, M. Parola, S. Colombatto, and E. Novo Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells Hepatology 42 6 2005 1339 1348
17. E. Novo, S. Cannito, E. Zamara, L. Valfre di Bonzo, A. Caligiuri, and C. Cravanzola Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells Am J Pathol 170 6 2007 1942 1953
18. J. Medina, A.G. Arroyo, F. Sanchez-Madrid, and R. Moreno-Otero Angiogenesis in chronic inflammatory liver disease Hepatology 39 5 2004 1185 1195
19. M. Pinzani, and K. Rombouts Liver fibrosis: from the bench to clinical targets Dig Liver Dis 36 4 2004 231 242
20. S. Tugues, G. Fernandez-Varo, J. Munoz-Luque, J. Ros, V. Arroyo, and J. Rodes Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats Hepatology 46 6 2007 1919 1926
21. M. Hennenberg, J. Trebicka, C. Stark, A.Z. Kohistani, J. Heller, and T. Sauerbruch Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis Br J Pharmacol 157 2 2009 258 270
22. M. Mejias, E. Garcia-Pras, C. Tiani, R. Miquel, J. Bosch, and M. Fernandez Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats Hepatology 49 4 2009 1245 1256
23. H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, and D.J. Hicklin Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 52 9 2003 1347 1354
24. V.H. Shah, and J. Bruix Antiangiogenic therapy: not just for cancer anymore? Hepatology 49 4 2009 1066 1068
25. M. Kitade, H. Yoshiji, H. Kojima, Y. Ikenaka, R. Noguchi, and K. Kaji Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats Hepatology 44 4 2006 983 991
26. J.R. Jackson, M.P. Seed, C.H. Kircher, D.A. Willoughby, and J.D. Winkler The codependence of angiogenesis and chronic inflammation FASEB J 11 6 1997 457 465
27. D.H. Kang, J. Hughes, M. Mazzali, G.F. Schreiner, and R.J. Johnson Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function J Am Soc Nephrol 12 7 2001 1448 1457
28. D.H. Kang, A.H. Joly, S.W. Oh, C. Hugo, D. Kerjaschki, and K.L. Gordon Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1 J Am Soc Nephrol 12 7 2001 1434 1447 (Pubitemid 32666326)
29. C. Stockmann, Y. Kerdiles, M. Nomaksteinsky, A. Weidemann, N. Takeda, and A. Doedens Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis Proc Natl Acad Sci USA 107 9 2010 4329 4334
30. E. Patsenker, Y. Popov, F. Stickel, V. Schneider, M. Ledermann, and H. Sagesser Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis Hepatology 50 5 2009 1501 1511
31. M.S. Thimgan, and H.F. Yee Jr. Quantitation of rat hepatic stellate cell contraction: stellate cells' contribution to sinusoidal resistance Am J Physiol 277 1 Pt 1 1999 G137 G143
32. R. Bruno, S. Galastri, P. Sacchi, S. Cima, A. Caligiuri, and R. DeFranco Gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis Gut 59 4 2010 513 520
33. P. Lindblom, H. Gerhardt, S. Liebner, A. Abramsson, M. Enge, and M. Hellstrom Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall Genes Dev 17 15 2003 1835 1840
34. M. Pinzani PDGF and signal transduction in hepatic stellate cells Front Biosci 7 2002 d1720 d1726
35. S. Cao, U. Yaqoob, A. Das, U. Shergill, K. Jagavelu, and R.C. Huebert Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells J Clin Invest 120 7 2010 2379 2394
36. M. Neef, M. Ledermann, H. Saegesser, V. Schneider, N. Widmer, and L.A. Decosterd Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term J Hepatol 44 1 2006 167 175
37. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 6 2008 1655 1669
38. N. Bosselut, C. Housset, P. Marcelo, C. Rey, T. Burmester, and J. Vinh Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts Proteomics 10 5 2010 1017 1028
39. D.A. Langer, A. Das, D. Semela, N. Kang-Decker, H. Hendrickson, and S.F. Bronk Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species Hepatology 47 6 2008 1983 1993
40. L.D. DeLeve, X. Wang, L. Hu, M.K. McCuskey, and R.S. McCuskey Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation Am J Physiol Gastrointest Liver Physiol 287 4 2004 G757 G763
41. L.D. Deleve, X. Wang, and Y. Guo Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence Hepatology 48 3 2008 920 930
42. V. Shah, F. Haddad, G. Garcia-Cardena, J. Frangos, A. Mennone, and R. Groszmann Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of hepatic resistance J Clin Invest 100 1997 2923 2930
43. V.J. Desmet, and T. Roskams Cirrhosis reversal: a duel between dogma and myth J Hepatol 40 5 2004 860 867
44. Y. Iimuro, R.M. Gallucci, M.I. Luster, H. Kono, and R.G. Thurman Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat Hepatology 26 6 1997 1530 1537
45. S. Naveau, S. Chollet-Martin, S. Dharancy, P. Mathurin, P. Jouet, and M.A. Piquet A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis Hepatology 39 5 2004 1390 1397
46. N.C. Boetticher, C.J. Peine, P. Kwo, G.A. Abrams, T. Patel, and B. Aqel A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis Gastroenterology 135 6 2008 1953 1960
47. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 4 2008 378 390